"Europe Electrophysiology Market" - Trends Industry and Forecast to 2024

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44-161-394-0625
Want create site? Find Free WordPress Themes and plugins.

Europe Electrophysiology Market – Industry Trends and Forecast to 2024

Europe
Upcoming Reports
Europe Electrophysiology Market
  • No of pages :
    175
  • No of Figures:
    30
  • No of Tables:
    125
  • Report Type:
    Upcoming
  • Category:

Europe Electrophysiology Market, By Type (EP Monitoring Devices, EP Treatment Devices), By Product Type(EP Ablation Catheters, EP Diagnostic Catheters, EP Laboratory Devices, Access Devices), By Indication(Atrial Fibrillation, Atrial Flutter, Ventricular Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Wolff-Parkinson-White (WPW) Syndrome And Atrioventricular Nodal Reentry Tachycardia), By Country (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzeland, Rest Of Europe) – Industry Trends and Forecast to 2024

Want create site? Find Free WordPress Themes and plugins.

Europe Electrophysiology Market is expected to reach USD 9.3 billion by 2024 from USD 5.4 billion in 2016, growing at a CAGR of 7.3% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Europe Electrophysiology Market

FIGURE:   ELECTROPHYSIOLOGY ABLATION CATHETERS  MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ELECTROPHYSIOLOGY MARKET  IN 2017

Electrophysiology basically deals about the electrical properties of the cells and tissues inside human body. Electrophysiological devices are present in wide range having various properties. In very short period of time, electrophysiology has made an important place in healthcare industry especially in case of the cardiovascular diseases. According to WHO, about 50% deaths in European region are caused because of cardiovascular diseases. However 80% of premature heart diseases and stroke are preventable.

Also Food and Drug administration (FDAs) regulatory activities impact patients and clinicians from new technologies and drugs which are available for allowing the conduction of clinical studies of investigational products, from monitoring event reports to overseeing the conduction of product calls. The technological superiority and precision is the main factor driving the market for electrophysiology in the period of 2017 to 2024. Electrophysiology provides better information about electrical system of heart as compared to other tests. For example, angiography helps knowing number of possible blockages in heart. Electrophysiology helps doctors in accurately diagnosing the cause of heart rhythm problem, find the source of cause and thus test medications for treating it.

However the main restraints of using electrophysiological devices are that they are costly. One of the biggest issues is that neither drugs nor the treatment procedure like catheter ablation can decrease the risk of stroke. However these devices help in knowing the symptoms. One more restraint is the lack of availability of the Europe electrophysiology market is segmented on the basis of type, product type, and indication and by geography.

On the basis of  type the market is segmented into EP monitoring devices and EP treatment devices.

On the basis of the product type the electrophysiology market is segmented into EP ablation catheters, EP diagnostic catheters, EP laboratory devices and access devices.

Based on indication the electrophysiology market is segmented into atrial fibrillation, atrial flutter, ventricular fibrillation, ventricular tachycardia, atrial tachycardia, Wolff-Parkinson-white (WPW) syndrome and atrioventricular nodal reentry tachycardia.

Based on geography the market is segmented into 11 countries such as Germany, France, U.K., Belgium, Switzerland, Netherlands, Italy, Spain, Russia, Turkey and Rest of Europe. In 2017, Germany is expected to dominate the market with 31.7% market share. However the market for France is expected to grow at the highest CAGR in the forecast period 2017 to 2024.

The Europe electrophysiology market is highly operated by various companies in local regions. The major players in this market have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the examples for these strategies are that, on 15th December, 2016, St. Jude medical announced FDA clearance of EnSite precision cardiac mapping system and Advisor FL Circular Mapping Catheter. The report also provides market share by company of electrophysiology market in Europe, Germany, France and U.K.

Some of the major players operating in this market are AtriCure, Inc. , Biosense Webster, Inc, Biotronik SE & Co. KG, Boston Scientific Corporation, CardioFocus, Inc., Endosense SA, Medtronic CryoCath LP, Mogul Enterprises, Inc, Osypka AG, Pioneer Medical Devices AG, St. Jude Medical, Inc., TZ Medical, Inc., Koninklijke Philips N.V., GE Healthcare, Boston Scientific, Siemens AG and many others.

Did you find apk for android? You can find new Free Android Games and apps.
Choose Licence Type

Enterprise, Single User

Want create site? Find Free WordPress Themes and plugins.

1. INTRODUCTION

      1.1. OVERVIEW OF THE EUROPE ELECTROPHYSIOLOGY MARKET
      1.2. MARKET SEGMENTATION & COVERAGE
                     1.2.1. CURRENCY AND PRICING 
                     1.2.2. LIMITATION
                     1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

      2.1. KEY TAKEAWAYS
      2.2. ARRIVING AT THE EUROPE ELECTROPHYSIOLOGY MARKET SIZE
                     2.2.1. MARKET CRACKDOWN APPROACH 
                     2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                     2.2.3. DATA TRIANGULATION
                     2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                     2.2.5. PRODUCT PIPELINE ANALYSIS
                     2.2.6. PORTER’S FIVE FORCES MATRIX

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. EUROPE ELECTROPHYSIOLOGY MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                       4.3.1. DRIVERS
                                     4.3.1.1. RISING PREVALENCE OF CHRONIC DISEASE SUCH AS CARDIOVASCULAR DISEASES
                                     4.3.1.2. INCREASED PATIENT AWARENESS ABOUT DISGNOSIS AND TREATMENT
                                     4.3.1.3. AGEING EUROPE POPULATION
                                     4.3.1.4. NUMBER OF CARDIAC DEVICE IMPLANTATIONS
                       4.3.2. RESTRAINTS
                       4.3.3. OPPURTUNITIES
                       4.3.4. THREATS
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. EXECUTIVE SUMMARY

6. EUROPE ELECTROPHYSIOLOGY MARKET, BY TYPE

       6.1. OVERVIEW
       6.2. EUROPE ELECTROPHYSIOLOGY, BY TYPE
                       6.2.1. ELECTROPHYSIOLOGY MONITORING DEVICES
                                     6.2.1.1. ELECTROCARDIOLOGY
                                     6.2.1.2. HOLTER MONITORING DEVICES
                                     6.2.1.3. EVENT MONITORS
                                     6.2.1.4. DIAGNOSTIC CATHETERS
                                     6.2.1.5. X-RAY SYSTEMS
                       6.2.2. ELECTROPHYSIOLOGY TREATMENT DEVICES
                                     6.2.2.1. ABLATION CATHETERS
                                     6.2.1.2. PACE MAKERS
                                     6.2.1.3. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
                                     6.2.1.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-D)
                                     6.2.1.5. CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS (CRT-P)
                                     6.2.1.4. IMPLANTABLE LOOP RECORDERS

7. EUROPE ELECTROPHYSIOLOGY MARKET, BY PRODUCT TYPE

       7.1. OVERVIEW
       7.2. EUROPE ELECTROPHYSIOLOGY, BY PRODUCT TYPE
                       7.2.1. ELECTROPHYSIOLOGY ABLATION CATHETERS
                                     7.2.1.1. RADIOFREQUENCY
                                     7.2.1.2. CRYOBLATION
                                     7.2.1.3. LASER ABLATION
                                     7.2.1.4. NAVIGATIONAL ADVANCED MAPPING ACCESSORIES
                                     7.2.1.5. MICROWAVE
                       7.2.2. ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
                                     7.2.2.1. CONVENTIONAL EP DIAGNOSTIC CATETERS
                                     7.2.1.2. ADVANCED EP DIAGNOSTIC
                                     7.2.1.3. ULTRASOUND EP DIAGNOSTIC
                       7.2.3. ELECTROPHYSIOLOGY LABORATORY DEVICES
                                     7.2.1.1. X-RAY SYSTEMS
                                     7.2.1.2. 3-D MAPPING SYSTEMS
                                     7.2.1.3. REMOTE STEERING SYSTEMS
                                     7.2.1.4. INTRA CARDIAC ECHOCARDIOGRAPHIC SYSTEMS(ICE)
                                     7.2.1.5. RADIO FREQUENCY (RF) ABLATION GENERATORS
                                     7.2.1.6. EP RECORDING SYSTEMS                 
                           7.2.4. ACCESS DEVICES          

8. EUROPE ELECTROPHYSIOLOGY MARKET, BY INDICATION

       8.1. OVERVIEW
       8.2. EUROPE ELECTROPHYSIOLOGY, BY INDICATION
                       8.2.1. ATRIAL FIBRILLATION
                       8.2.2. ATRIAL FLUTTER
                       8.2.3.  VENTRICULAR FIBRILLATION
                       8.2.4. VENTRICULAR TACHYCARDIA
                       8.2.1. ATRIAL TACHYCARDIA
                       8.2.2. WOLFF- PARKINSON- WHITE SYNDROME(WPW)
                       8.2.3. ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA

9. EUROPE ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY

       9.1. COUNTRYWISE EUROPE ELECTROPHYSIOLOGY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                       9.1.1. EUROPE
                                     9.1.2.1. GERMANY
                                     9.1.2.2. FRANCE
                                     9.1.2.3. U.K.
                                     9.1.2.4. ITALY
                                     9.1.2.5. SPAIN
                                     9.1.2.6. RUSSIA
                                     9.1.2.7. TURKEY
                                     9.1.2.8. BELGIUM
                                     9.1.2.9. NETHERLANDS
                                     9.1.2.10. SWITZERLAND
                                     9.1.2.11. REST OF EUROPE
       9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. EUROPE ELECTROPHYSIOLOGY MARKET: COMPETITIVE LANDSCAPE

       10.1. EUROPE ELECTROPHYSIOLOGY MARKET : COMPANY SHARE ANALYSIS
       10.2. GERMANY ELECTROPHYSIOLOGY MARKET MARKET: COMPANY SHARE ANALYSIS
       10.3. FRANCE  ELECTROPHYSIOLOGY MARKET MARKET: COMPANY SHARE ANALYSIS
       10.4. U.K.  ELECTROPHYSIOLOGY MARKET: COMPANY SHARE ANALYSIS
       10.5. MERGERS & ACQUISITIONS
       10.6. NEW PRODUCT DEVELOPMENT & APPROVALS
       10.7. EXPANSIONS
       10.8. REGULATORY CHANGES
       10.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11. GERMANY ELECTROPHYSIOLOGY MARKET: COMPANY SHARE ANALYSIS, COMPANY PROFILES

         11.1. ABOTT LABORATORIES
                            11.1.1. COMPANY OVERVIEW
                            11.1.2. REVENUE ANALYSIS
                            11.1.3. PRODUCT PORTFOLIO
                            11.1.4. RECENT DEVELOPEMENTS
                            11.1.5. DATA BRIDGE ANALYSIS
         11.2. BIOTRONIK SE & CO. KG
                            11.2.1.  COMPANY OVERVIEW
                            11.2.2. REVENUE ANALYSIS
                            11.2.3. PRODUCT PORTFOLIO
                            11.2.4. RECENT DEVELOPEMENTS
                            11.2.5. DATA BRIDGE ANALYSIS
         11.3. BOSTON SCIENTIFIC
                            11.3.1. COMPANY OVERVIEW
                           11.3.2. REVENUE ANALYSIS
                           11.3.3. PRODUCT PORTFOLIO
                           11.3.4. RECENT DEVELOPEMENTS
                           11.3.5. DATA BRIDGE ANALYSIS
         11.4. GE HEALTHCARE
                             11.4.1. COMPANY OVERVIEW
                             11.4.2. REVENUE ANALYSIS
                             11.4.3. PRODUCT PORTFOLIO
                             11.4.4. RECENT DEVELOPEMENTS
                             11.4.5. DATA BRIDGE ANALYSIS
         11.5. KONINKLIJKE PHILIPS N.V..
                             11.5.1. COMPANY OVERVIEW
                            11.5.2. REVENUE ANALYSIS
                            11.5.3. PRODUCT PORTFOLIO
                            11.5.4. RECENT DEVELOPEMENTS
                            11.5.5. DATA BRIDGE ANALYSIS
         11.6. MEDTRONIC, INC. 
                             11.6.1. COMPANY OVERVIEW
                             11.6.2. REVENUE ANALYSIS
                             11.6.3. PRODUCT PORTFOLIO
                              11.6.4. RECENT DEVELOPEMENTS
                              11.6.5. DATA BRIDGE ANALYSIS
         11.7. ST. JUDE MEDICAL
                            11.7.1. COMPANY OVERVIEW
                            11.7.2. REVENUE ANALYSIS
                            11.7.3. PRODUCT PORTFOLIO
                            11.7.4. RECENT DEVELOPEMENTS
                            11.7.5. DATA BRIDGE ANALYSIS
         11.8. SIEMENS AG
                             11.8.1. COMPANY OVERVIEW
                             11.8.2. REVENUE ANALYSIS
                             11.8.3. PRODUCT PORTFOLIO
                             11.8.4. RECENT DEVELOPEMENTS
                             11.8.5. DATA BRIDGE ANALYSIS
         11.9. MICROPORT SCIENTIFIC CORPORATION
                             11.9.1. COMPANY OVERVIEW
                             11.9.2. REVENUE ANALYSIS
                             11.9.3. PRODUCT PORTFOLIO
                             11.9.4. RECENT DEVELOPEMENTS
                             11.9.5. DATA BRIDGE ANALYSIS
         11.10. OSYPKA AG
                             11.10.1. COMPANY OVERVIEW
                             11.10.2. REVENUE ANALYSIS
                             11.10.3. PRODUCT PORTFOLIO
                             11.10.4. RECENT DEVELOPEMENTS
                            11.10.5. DATA BRIDGE ANALYSIS
         11.11. ENDOSENSE SA
                             11.11.1. COMPANY OVERVIEW
                             11.11.2. REVENUE ANALYSIS
                             11.11.3. PRODUCT PORTFOLIO
                             11.11.4. RECENT DEVELOPEMENTS
                             11.11.5. DATA BRIDGE ANALYSIS
         11.12. ATRICURE, INC.
                             11.12.1. COMPANY OVERVIEW
                             11.12.2. REVENUE ANALYSIS
                             11.12.3. PRODUCT PORTFOLIO
                             11.12.4. RECENT DEVELOPEMENTS
                             11.12.5. DATA BRIDGE ANALYSIS
         11.13. CARDIOFOCUS, INC.
                             11.13.1. COMPANY OVERVIEW
                             11.13.2. REVENUE ANALYSIS
                             11.13.3. PRODUCT PORTFOLIO
                             11.13.4. RECENT DEVELOPEMENTS
                             11.13.5. DATA BRIDGE ANALYSIS
         11.14. MOGUL ENTERPRISES, INC.
                            11.14.1. COMPANY OVERVIEW
                            11.14.2. REVENUE ANALYSIS
                            11.14.3. PRODUCT PORTFOLIO
                            11.14.4. RECENT DEVELOPEMENTS
                            11.14.5. DATA BRIDGE ANALYSIS
         11.15. PIONEER MEDICAL DEVICES AG
                            11.15.1. COMPANY OVERVIEW
                            11.15.2. REVENUE ANALYSIS
                            11.15.3. PRODUCT PORTFOLIO
                            11.15.4. RECENT DEVELOPEMENTS
                            11.15.5. DATA BRIDGE ANALYSIS
         11.16. CATHEFFECTS INC
                            11.16.1. COMPANY OVERVIEW
                            11.16.2. REVENUE ANALYSIS
                            11.16.3. PRODUCT PORTFOLIO
                            11.16.4. RECENT DEVELOPEMENTS
                            11.16.5. DATA BRIDGE ANALYSIS
         11.17. JAPAN LIFELINE CO. LTD
                            11.17.1. COMPANY OVERVIEW
                            11.17.2. REVENUE ANALYSIS
                            11.17.3. PRODUCT PORTFOLIO
                           11.17.4. RECENT DEVELOPEMENTS
                           11.17.5. DATA BRIDGE ANALYSIS

12. APPENDIX

13. ABOUT DATA BRIDGE MARKET RESEARCH

Did you find apk for android? You can find new Free Android Games and apps.
Want create site? Find Free WordPress Themes and plugins.

Available on Request.

Did you find apk for android? You can find new Free Android Games and apps.
Want create site? Find Free WordPress Themes and plugins.

Available on Request.

Did you find apk for android? You can find new Free Android Games and apps.
Want create site? Find Free WordPress Themes and plugins.

Please fill in the below form and our sales representatives will get back to you.

Thank You

Did you find apk for android? You can find new Free Android Games and apps.
Want create site? Find Free WordPress Themes and plugins.

Thank You

Did you find apk for android? You can find new Free Android Games and apps.
Did you find apk for android? You can find new Free Android Games and apps.
`